Accès libre

Breast size impact on adjuvant radiotherapy adverse effects and dose parameters in treatment planning

Ivica Ratosa

Ivica Ratosa

Division of Radiotherapy, Institute of Oncology LjubljanaLjubljana, Slovenia
Recherchez cet auteur sur
Sciendo|Google Scholar
Ratosa, Ivica
, 
Aljasa Jenko

Aljasa Jenko

Division of Radiotherapy, Department of Medical Physics, Institute of Oncology LjubljanaLjubljana, Slovenia
Recherchez cet auteur sur
Sciendo|Google Scholar
Jenko, Aljasa
 et 
Irena Oblak

Irena Oblak

Division of Radiotherapy, Institute of Oncology LjubljanaLjubljana, Slovenia
Recherchez cet auteur sur
Sciendo|Google Scholar
Oblak, Irena
  
02 août 2018
Breast size impact on adjuvant radiotherapy adverse effects and dose parameters in treatment planning's Cover Image
À propos de cet article
Article précédent
Article suivant
Citez
Télécharger la couverture
Catégorie d'article: Review
Publié en ligne: 02 août 2018
Pages: 233 - 244
Reçu: 30 mars 2018
Accepté: 12 juin 2018
DOI: https://doi.org/10.2478/raon-2018-0026
Mots clés
© 2018 Ivica Ratosa, Aljasa Jenko, Irena Oblak, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Background

Breast radiotherapy is an established adjuvant treatment after breast conserving surgery. One of the important individual factors affecting the final cosmetic outcome after radiation is breast size. The purpose of this review is to summarise the clinical toxicity profile of adjuvant radiotherapy in women with breasts of various sizes, and to evaluate the treatment planning studies comparing target coverage and dose to thoracic organs at risk in relation to breast size.

Conclusions

Inhomogeneity and excessive radiation dose (hot spots) in the planning of target volume as well as large volume of the breast per se, all contribute to a higher rate of acute adverse events and suboptimal final cosmetic outcome in adjuvant breast cancer radiotherapy, regardless of the fractionation schedule. Improved homogeneity leads to a lower rate of ≥ grade 2 toxicity and can be achieved with three-dimensional conformal or modulated radiotherapy techniques. There may be an association between body habitus (higher body mass index, bigger breast size, pendulous breast, and large chest wall separation) and a higher mean dose to the ipsilateral lung and whole heart. A combination of the technical innovations (i.e. the breath-hold technique, prone position with or without holding breath, lateral decubitus position, and thermoplastic bra), dose prescription (i.e. moderate hypofractionation), and irradiated volume (i.e. partial breast irradiation) should be tailored to every single patient in clinical practice to mitigate the risk of radiation adverse effects.

Langue:
Anglais
Périodicité:
4 fois par an
Sujets de la revue:
Médecine, Médecine clinique, Médecine interne, Hématologie, oncologie, Radiologie
RSS Feed de la revue